000			02241 a2200589 4500
005			20250513110917.0
264		0	_c19970331
008			199703s 0 0 eng d
022			_a0085-2538
024	7		_a10.1038/ki.1997.20 _2doi
040			_aNLM _beng _cNLM
100	1		_aOikawa, T
245	0	0	_aModulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition. _h[electronic resource]
260			_bKidney international _cJan 1997
300			_a164-72 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAngiotensin II _xantagonists & inhibitors
650	0	4	_aAngiotensin Receptor Antagonists
650	0	4	_aAngiotensin-Converting Enzyme Inhibitors _xpharmacology
650	0	4	_aAnimals
650	0	4	_aAntihypertensive Agents _xpharmacology
650	0	4	_aCaptopril _xpharmacology
650	0	4	_aCytokines _xgenetics
650	0	4	_aEnalapril _xpharmacology
650	0	4	_aFibrin _xmetabolism
650	0	4	_aFibrinolysin _xmetabolism
650	0	4	_aFibrosis
650	0	4	_aGene Expression Regulation, Enzymologic _xphysiology
650	0	4	_aGrowth Substances _xgenetics
650	0	4	_aImidazoles _xpharmacology
650	0	4	_aIn Situ Hybridization
650	0	4	_aKidney _xchemistry
650	0	4	_aMale
650	0	4	_aPlasminogen Activator Inhibitor 1 _xgenetics
650	0	4	_aProteinuria _xdrug therapy
650	0	4	_aRNA, Messenger _xanalysis
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aRenal Circulation _xdrug effects
650	0	4	_aRenin _xantagonists & inhibitors
650	0	4	_aTetrazoles _xpharmacology
650	0	4	_aThrombosis _xdrug therapy
650	0	4	_aTissue Plasminogen Activator _xgenetics
650	0	4	_aUrokinase-Type Plasminogen Activator _xgenetics
650	0	4	_aVasoconstrictor Agents _xantagonists & inhibitors
700	1		_aFreeman, M
700	1		_aLo, W
700	1		_aVaughan, D E
700	1		_aFogo, A
773	0		_tKidney international _gvol. 51 _gno. 1 _gp. 164-72
856	4	0	_uhttps://doi.org/10.1038/ki.1997.20 _zAvailable from publisher's website
999			_c8986934 _d8986934